KARLA HOSTETLER: Open Payments
NPI 1669436366 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 28 payments from 12 companies in 2025. Trend: 2023 $530 · 2024 $244 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $158 |
| Medtronic, Inc. | 4 | $96 |
| PFIZER INC. | 4 | $71 |
| Lilly USA, LLC | 4 | $63 |
| ABBVIE INC. | 3 | $58 |
| Novo Nordisk Inc | 2 | $41 |
| Lundbeck LLC | 1 | $26 |
| Abbott Laboratories | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $22 |
Products named: FARXIGA, INTELLIS ADAPTIVESTIM, PREVNAR 20, REXULTI, BREZTRI, VRAYLAR, Ozempic, MOUNJARO.
Industry payments across KS — which companies pay providers there.
